| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/24/2002 | DE10034130A1 Heterocyclische Fluoralkenylthioether (lV) Heterocyclic fluoroalkenyl thioethers (IV) |
| 01/24/2002 | DE10030466A1 Nukleotid- und Aminosäurensequenzen eines zellulären Repressors der DNA Replikation des Herpesvirus Epstein-Barr Nucleotide and amino acid sequences of a cellular repressor of DNA replication of the herpes virus Epstein-Barr |
| 01/24/2002 | CA2450747A1 Derivatives of laspartomycin and preparation and use thereof |
| 01/24/2002 | CA2450372A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| 01/24/2002 | CA2418288A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 01/24/2002 | CA2418214A1 Antimicrobial agent |
| 01/24/2002 | CA2418162A1 Use of il-8 receptor antagonists in the treatment of virus infections |
| 01/24/2002 | CA2416695A1 Process for the preparation of highly pure crystalline (r,s) - cefuroxime axetil |
| 01/24/2002 | CA2415965A1 Oxazolidinone derivatives as antimicrobials |
| 01/24/2002 | CA2415961A1 Production method of 1-substituted-1,2,3-triazole derivatives |
| 01/24/2002 | CA2415938A1 Alpha-msh related compounds and methods of use |
| 01/24/2002 | CA2415935A1 Novel 6-heteroarylphenanthridines |
| 01/24/2002 | CA2415906A1 Compositions containing diacyltartaric salts of (e)-metanicotine |
| 01/24/2002 | CA2415751A1 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | CA2415701A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | CA2415665A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 01/24/2002 | CA2415481A1 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 01/24/2002 | CA2415347A1 Adenovirus vectors comprising introns |
| 01/24/2002 | CA2415187A1 Dna vaccines encoding hiv accessory proteins |
| 01/24/2002 | CA2414846A1 Immunological combinations for prophylaxis and therapy of helicobacter pylori infection |
| 01/24/2002 | CA2413582A1 Use of a spla2 inhibitor for the treatment of sepsis |
| 01/23/2002 | EP1174523A2 Method for detecting an HBV-derived nucleic acid target sequence |
| 01/23/2002 | EP1174514A1 Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement |
| 01/23/2002 | EP1174506A1 C-terminal Erns peptide and analogues thereof |
| 01/23/2002 | EP1174505A1 (Poly)peptides for the preparation of vaccines against Bordetella pertussis and/or Bordetella parapertussis, vaccines based upon such (poly)peptides, and antibodies against such peptides |
| 01/23/2002 | EP1174503A1 Novel proteins, gene encoding the same and method of utilization thereof |
| 01/23/2002 | EP1174440A1 A selectively-expressed epitope on the human CD38 molecule detected by a phage display library-derived human scFv antibody fragment |
| 01/23/2002 | EP1174147A1 Reversal of antibiotic resistance with lysozyme dimer |
| 01/23/2002 | EP1174133A1 Pharmaceutical compositions containing amorphous mupirocin |
| 01/23/2002 | EP1174132A1 Percutaneous absorption preparations containing oxybutynin |
| 01/23/2002 | EP1173767A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/23/2002 | EP1173569A1 Synthetic signalling molecules |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173561A2 Non-invasive method for detecting target rna |
| 01/23/2002 | EP1173485A1 Human antibodies to staphylococcus aureus |
| 01/23/2002 | EP1173481A1 Inactivated cytokines for immunisation |
| 01/23/2002 | EP1173480A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173475A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 01/23/2002 | EP1173473A1 Antifungal agents isolated from pseudomonas syringae |
| 01/23/2002 | EP1173472A1 Cyclic hexapeptides having antibiotic activity |
| 01/23/2002 | EP1173471A2 Pseudomycin analogs |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173467A1 Chemokine-derived synthetic peptides |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173455A2 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments |
| 01/23/2002 | EP1173451A1 New antioxidative vitamin b 6 analogs |
| 01/23/2002 | EP1173442A2 Methods for preparing antiviral calanolide compounds |
| 01/23/2002 | EP1173439A1 Haloalkoxy imidazonaphthyridines |
| 01/23/2002 | EP1173220A2 Targeting of infectious agents bearing host cell proteins |
| 01/23/2002 | EP1173215A1 Over-coated chewing gum formulations |
| 01/23/2002 | EP1173195A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/23/2002 | EP1173194A2 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
| 01/23/2002 | EP1173189A1 Asialocytokines and treatment of liver disease |
| 01/23/2002 | EP1173183A2 Use of compounds with a nitrogen-oxygen heterocycle |
| 01/23/2002 | EP1173170A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/23/2002 | EP1173161A2 Glucamine compounds for treating hepatitis virus infections |
| 01/23/2002 | EP1135395A4 Crystalline salts of a carbapenem antibiotic |
| 01/23/2002 | EP0980254B1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| 01/23/2002 | EP0854711B1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 01/23/2002 | EP0839046B1 Tnf receptor and steroid hormone dhea in a combined therapy |
| 01/23/2002 | EP0833826B1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 01/23/2002 | EP0813539A4 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 01/23/2002 | EP0724586B1 Process for preparing n-(2,6-dichloro-3-methylphenyl)-5-7-dihalo[1,2,4]triazolo[1,5a]pyrimidine-2-sulfonamide by cyclization and halo-dehydroxylation |
| 01/23/2002 | EP0658118B1 Vaccines against group c neisseria meningitidis |
| 01/23/2002 | CN1332803A Streptococcus antigens |
| 01/23/2002 | CN1332747A 2'-fluoronucleosides |
| 01/23/2002 | CN1332746A Novel derivatives from class of oleandomycin |
| 01/23/2002 | CN1332741A Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 01/23/2002 | CN1332731A Substituted benzimidazoles and their prep. and use |
| 01/23/2002 | CN1332729A 4-oxo-1,4-dihybro-3-quinolinecarboxamides as antiviral agents |
| 01/23/2002 | CN1332725A Thiourea inhibitors of herpes viruses |
| 01/23/2002 | CN1332711A Vitamin D analogues |
| 01/23/2002 | CN1332648A Method of providing cosmetic/medical therapy |
| 01/23/2002 | CN1332634A Gamma & T cell immunoactivity potentiators containing shiitake mushroom hypha extract |
| 01/23/2002 | CN1332626A Inhalation system |
| 01/23/2002 | CN1332015A Freeze dried dyad live hepatitis A and parotitis vaccine |
| 01/23/2002 | CN1332013A Granule for clearing away heat and dispelling watness-evil |
| 01/23/2002 | CN1332003A External-use medicine for treating beriberi and its prepn process and usage thereof |
| 01/23/2002 | CN1332001A Tonic medicine for phthisis patient and its prepn |
| 01/23/2002 | CN1331972A Medicine for preventing and treating white bottom disease of turtle |
| 01/23/2002 | CN1078210C Watersoluble azole antifungals |
| 01/22/2002 | US6340755 5H-Pyrano[2,3-d: 6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity |
| 01/22/2002 | US6340742 Erythropoietin conjugates |
| 01/22/2002 | US6340706 Antiinflammatory, antiallergic and antiproliferative agents |
| 01/22/2002 | US6340690 Inhibiting hepatitis or herpes viral infections |
| 01/22/2002 | US6340685 Antiinflammatory agents |
| 01/22/2002 | US6340681 Useful as analgesics in mammals |
| 01/22/2002 | US6340680 Oxazinoquinolones useful for the treatment of viral infections |
| 01/22/2002 | US6340673 Administering at or near a site of a tumor of tumorigenic disease a herpes simplex virus vector lacking an expressible .gamma..sub.1 34.5 gene, whereby the growth of tumor is suppressed |
| 01/22/2002 | US6340577 Protein fragments for use in protein targeting |
| 01/22/2002 | US6340476 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| 01/22/2002 | CA2115564C Escherichia coli o-polysaccharide-protein conjugate vaccine |
| 01/22/2002 | CA2102457C Erythromycin derivatives, process for the preparation thereof, and use thereof as medicaments |
| 01/22/2002 | CA2082820C Derivatives of 6-aminooctahydroindolizinetriol |
| 01/22/2002 | CA2057711C Antibiotic agent |
| 01/22/2002 | CA2050304C Pharmaceutical composition useful in preventing or treating tumors induced by papillomaruses |
| 01/18/2002 | CA2349743A1 Diagnostic assay |
| 01/17/2002 | WO2002004646A1 Expression system |